IAK (IAK) Stock Price & Analysis
IAK (IAK) rose 0.75% to USD 132.59 as of June 10, 2026 at 13:05 UTC, according to Nexqual real-time market data.
IAK last closed at USD 131.6; the session ranged USD 131.6–133.34 on volume of 29,927 shares. Market capitalization is —, with a 52-week range of USD 124.62–138.66 (PCX). Source: Nexqual, June 10, 2026 at 13:05 UTC.
Key Statistics (as of June 10, 2026 at 13:05 UTC)
| Price | USD 132.59 |
|---|---|
| Change | ▲ 0.75% (up) |
| Previous Close | USD 131.6 |
| Open | USD 131.63 |
| Day Range | USD 131.6 – 133.34 |
| 52-Week Range | USD 124.62 – 138.66 |
| Volume | 29,927 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (IAK)
Nexqual's technical model rates IAK "BUY" based on 4 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 13:05 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.71 (neutral) |
| vs SMA50 | Above (USD 131.18) |
| MACD | -0.32 (negative) |
Financial Health Score (IAK)
Nexqual rates IAK's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 13:05 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IAI | iShares U.S. Broker-Dealers & S | USD 180.17 | ▲ 0.11% |
| KIE | State Street SPDR S&P Insurance | USD 56.94 | ▲ 0.07% |
| IAT | iShares U.S. Regional Banks ETF | USD 59.41 | ▲ 1.26% |
| IYG | iShares U.S. Financial Services | USD 88.8 | ▲ 0.63% |
| IHE | iShares U.S. Pharmaceutical ETF | USD 93.79 | ▲ 1.19% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:05 UTC. This page is informational and not investment advice.